查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405836

止吐藥市場規模、佔有率和趨勢分析報告：按藥物類型、最終用途、地區和細分市場預測，2024-2030

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

止吐藥市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球止吐藥市場規模將達到112億美元，2024年至2030年複合年成長率為5.98%。

主要企業策略舉措的增加以及引起噁心和嘔吐的各種疾病的流行等因素正在推動市場需求的成長。

主要產業參與者活動的增加是加強止吐藥需求的主要因素之一。市場參與企業正在採取各種舉措，例如聯盟、收購、新產品發布、產品核准和業務擴張，以加強他們在止吐藥市場的地位。例如，2020年5月，美國食品藥物管理局核准了Helsinn Group的AKYNZEO注射液用於預防化療引起的噁心和嘔吐。因此，新產品核准的增加預計將推動未來幾年的行業成長。

除了化療和術後噁心嘔吐（PONV）等關鍵適應症外，食物中毒和飲酒等其他情況也在預測期內推動了這些藥物的需求。 NCBI 於 2021 年 11 月發表的一篇論文表明，某些非處方止吐藥（例如次水楊酸鉍）可以有效緩解與食物中毒相關的噁心和嘔吐。

此外，2022 年 10 月發表在 Frontiers 上的一項研究發現，5-羥色胺受體拮抗Ondansetron是治療早發性酒精成癮(EOA) 患者酒精使用障礙的有效方法。因此，由於飲酒消費量增加和食物中毒爆發，止吐藥的需求預計將會增加。

止吐藥市場報告亮點

  • 從藥物類型來看，到2023年，5-羥色胺受體拮抗將以29.71%的佔有率佔據市場主導地位，這種主導地位可歸因於癌症患者數量的增加和5-羥色胺受體拮抗的使用增加。
  • 從應用來看，由於越來越多的針對化療相關噁心和嘔吐的產品上市，化療領域是市場最大的收益貢獻者，到2023年將佔45.70%的佔有率。
  • 在最終用途領域，零售藥品領域佔據市場主導地位，2023年收益佔有率為47.91%。相比之下，其他細分市場預計在預測期內將成長最快。
  • 由於輝瑞、默克和葛蘭素史克等主要參與者的存在，北美地區在 2023 年以 36.52% 的佔有率佔據市場主導地位。同時，亞太地區預計將在預測期內出現最快的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 藥品品種經營分析

  • 止吐藥市場：藥種波動分析
  • 血清素受體拮抗
  • 抗膽鹼能藥物
  • 多巴胺受體拮抗
  • 神經激肽受體拮抗
  • 其他

第 5 章應用程式的商業分析

  • 止吐藥市場：應用變化分析
  • 化療
  • 胃腸炎
  • 術後
  • 其他

第 6 章最終用途業務分析

  • 止吐藥市場：最終用途變化分析
  • 醫院和診所
  • 零售藥房
  • 其他

第7章 區域業務分析

  • 2023 年和 2030 年按地區分類的止吐藥市場佔有率
  • 北美洲
    • 北美止吐藥市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲止吐藥市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太止吐藥市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲止吐藥市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 止吐藥市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年公司市場佔有率分析
  • 公司簡介/名單
    • Pfizer Inc.
    • Cipla Inc.
    • Merck KGaA
    • Eagle Pharmaceuticals, Inc.
    • Johnson &Johnson Services, Inc.
    • GSK plc.
    • Astellas Pharma Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Viatris Inc.
    • Baxter
Product Code: GVR-4-68040-165-9

Antiemetics Drugs Market Growth & Trends:

The global antiemetics drugs market size is expected to reach USD 11.20 billion by 2030, exhibiting a CAGR of 5.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing strategic initiatives of the key players coupled with the increasing prevalence of various diseases causing nausea and vomiting are propelling market demand forward.

The rising activity of major industry players is one of the major factors bolstering the demand for antiemetics drugs. Industry participants are undertaking various initiatives such as partnerships, acquisitions, new product launches, product approvals, and expansions to strengthen their position in the antiemetics drugs market. For instance, in May 2020, the U.S. Food and Drug Administration approved an AKYNZEO injection from the Helsinn Group for the prevention of nausea and vomiting induced by chemotherapy. Thus, increasing novel product approvals are anticipated to drive industry growth in the coming years.

In addition to key indications such as chemotherapy and postoperative nausea and vomiting (PONV), other conditions such as food poisoning and alcohol consumption are also driving the demand for these medicines over the forecast period. An article published by NCBI in November 2021 suggests that certain over-the-counter antiemetics, such as Bismuth Subsalicylate, are effective in addressing nausea and vomiting associated with food poisoning.

Moreover, a study published in Frontiers in October 2022 reported that ondansetron, a serotonin receptor antagonist, is an effective treatment for alcohol use disorder in patients with early onset alcoholism (EOA). Consequently, the demand for antiemetic medicines is expected to rise in response to increased alcohol consumption and incidents of food poisoning.

Antiemetics Drugs Market Report Highlights:

  • On the basis of drug type, the serotonin-receptor antagonists segment dominated the market at 29.71% in 2023 and this dominance can be attributed to the rising cases of cancer coupled with the increasing use of serotonin-receptor antagonist drugs.
  • Based on the application, the chemotherapy segment was the largest revenue contributor to the market with a share of 45.70% in 2023 owing to the increasing product launches targeting nausea and vomiting associated with chemotherapy.
  • In the end-use segment, the retail pharmacy segment dominated the market with a revenue share of 47.91% in 2023. In contrast, the other segment is anticipated to register the fastest growth over the forecast period.
  • The North America region dominated the market with a share of 36.52% in 2023 owing to the presence of major players like Pfizer, Merck Co & Inc, and GSK plc. On the other hand, Asia Pacific is expected to showcase the fastest growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Segment Definitions
    • 1.1.1. Drug Type Segment
    • 1.1.2. Application Segment
    • 1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Research Assumptions

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Target Diseases
      • 3.2.1.2. Rising Investments by Industry Participants in R&D Activities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Adverse Effects Associated with Anti emetics Drugs
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Drug Type Business Analysis

  • 4.1. Antiemetics Drugs Market: Drug Type Movement Analysis
  • 4.2. Serotonin-Receptor Antagonists
    • 4.2.1. Serotonin-Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.3. Anticholinergics
    • 4.3.1. Anticholinergics Market, 2018 - 2030 (USD Million)
  • 4.4. Dopamine Receptor Antagonists
    • 4.4.1. Dopamine Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.5. Neurokinin Receptor Antagonists
    • 4.5.1. Neurokinin Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Other Drug Types Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Antiemetics Drugs Market: Application Movement Analysis
  • 5.2. Chemotherapy
    • 5.2.1. Chemotherapy Market, 2018 - 2030 (USD Million)
  • 5.3. Gastroenteritis
    • 5.3.1. Gastroenteritis Market, 2018 - 2030 (USD Million)
  • 5.4. Post-Operative Surgery
    • 5.4.1. Post Operative Surgery Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Antiemetics Drugs Market: End-use Movement Analysis
  • 6.2. Hospital & Clinics
    • 6.2.1. Hospital & Clinics Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Other End-use Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Antiemetics Drugs Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Antiemetics Drugs Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Pfizer Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Cipla Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Eagle Pharmaceuticals, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Johnson & Johnson Services, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GSK plc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Astellas Pharma Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. GLENMARK PHARMACEUTICALS LTD.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Viatris Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Baxter
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 4 Global Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Antiemetics Drugs Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 9 North America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 22 UK Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 France Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 28 France Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Spain Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 31 Spain Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Spain Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Norway Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 40 Norway Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 50 China Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 China Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 India Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 56 India Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
  • Table 78 Argentina Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 82 MEA Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 88 UAE Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
  • Table 91 Saudi Arabia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Antiemetics drugs market segmentation
  • Fig. 8 Market snapshot, 2023
  • Fig. 9 Market Trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Global antiemetics drugs market: Drug type outlook and key takeaways
  • Fig. 15 Global antiemetics drugs market: Drug type movement analysis
  • Fig. 16 Global antiemetics drugs market, for serotonin-receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 17 Global antiemetics drugs market, for anticholinergics, 2018 - 2030 (USD Million)
  • Fig. 18 Global antiemetics drugs market, for dopamine receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 19 Global antiemetics drugs market, for neurokinin receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 20 Global antiemetics drugs market, for other drug types, 2018 - 2030 (USD Million)
  • Fig. 21 Global antiemetics drugs market: Application outlook and key takeaways
  • Fig. 22 Global antiemetics drugs market: Application movement analysis
  • Fig. 23 Global antiemetics drugs market, for chemotherapy, 2018 - 2030 (USD Million)
  • Fig. 24 Global antiemetics drugs market, for gastroenteritis, 2018 - 2030 (USD Million)
  • Fig. 25 Global antiemetics drugs market, for post-operative surgery, 2018 - 2030 (USD Million)
  • Fig. 26 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
  • Fig. 27 Global antiemetics drugs market: End-use outlook and key takeaways
  • Fig. 28 Global antiemetics drugs market: End-use movement analysis
  • Fig. 29 Global antiemetics drugs market, for hospital & clinics, 2018 - 2030 (USD Million)
  • Fig. 30 Global antiemetics drugs market, for retail pharmacy, 2018 - 2030 (USD Million)
  • Fig. 31 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Global antiemetics drugs market: Region movement analysis
  • Fig. 35 North America antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 36 US antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 40 UK antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 41 France antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 China antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 50 India antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait antiemetics drugs market, 2018 - 2030 (USD Million)